Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 EUR | +0.29% | +5.83% | -15.75% |
May. 13 | Inventiva: additional Phase 2 results in NASH | CF |
Apr. 22 | Inventiva: UBS Group falls below 5% threshold | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.75% | 194M | |
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.46% | 21.25B | |
-5.85% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- IVA Stock
- News Inventiva
- Inventiva Gains 17% on Licensing Deal for Fatty Liver Disease Drug Candidate in Japan, South Korea